Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Second Amended and Restated Certificate of Incorporation of the Registrant
- 3.2 Bylaws of the Registrant
- 3.3 Amended and Restated Bylaws of the Registrant Effective Immediately Following the Closing of This Offering
- 4.2 Warrant Dated January 24, 2018 Issued to Liquid Patent Advisors, LLC
- 4.3 Warrant Dated March 13, 2018 Issued to National Securities Corporation
- 4.4 Warrant Dated March 22, 2018 Issued to National Securities Corporation
- 4.5 Warrant Dated May 16, 2019 Issued to National Securities Corporation
- 4.6 Warrant Dated May 23, 2019 Issued to National Securities Corporation
- 10.1 Engagement Agreement Dated January 26, 2018 Between Liquid Patent Advisors, LLC and the Registrant
- 10.2 Securities Purchase Agreement Dated March 13, 2018 by and Among the Registrant and the Buyers Named Therein
- 10.3 Amended and Restated Registration Rights Agreement Dated May 16, 2019 by and Among the Registrant and Certain of Its Stockholders
- 10.4 Contribution and Subscription Agreement Dated January 24, 2018 Between the Registrant and Lung Therapeutics, Inc.
- 10.5 Patent License Agreement Dated July 8, 2015 Between Lung Therapeutics, Inc. and the University of Texas at Austin
- 10.6 TFF Pharmaceuticals, Inc. 2018 Stock Incentive Plan
- 10.7 Amended and Restated Consulting Agreement Dated December 20, 2018 Between Robert Mills and the Registrant
- 10.8 Consulting Agreement Dated February 12, 2018 Between DR. Brian Windsor and the Registrant
- 10.9 Consulting Agreement Dated April 23, 2018 Between Glenn Mattes and the Registrant
- 10.10 Lease Agreement Dated October 19, 2018
- 10.11 Executive Employment Agreement Dated December 20, 2018 Between Glenn Mattes and the Registrant
- 10.12 Securities Purchase Agreement Dated May 16, 2019 by and Among the Registrant and the Buyers Named Therein
- 10.13 Amendment NO.1 to Patent License Agreement Dated November 30, 2018 Between the Registrant and the University of Texas at Austin
- 10.14 Employment Agreement, Dated February 15, 2019, by and Between the Registrant and Kirk Coleman
- 21.1 List of Subsidiaries
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm
TFFP similar filings
Filing view
External links
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of TFF Pharmaceuticals, Inc. on Form S-1 of our report dated February 15, 2019, with respect to our audits of the financial statements of TFF Pharmaceuticals, Inc. as of December 31, 2018 and 2017 (Predecessor) and for the period from January 24, 2018 to December 31, 2018, period from January 1, 2018 to January 23, 2018 (Predecessor) and year ended December 31, 2017 (Predecessor) which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcumllp
Marcumllp
New York, NY
August 20, 2019